Better Choice Company to Acquire SRx Health Solutions for Approximately $125 Million

Better Choice Company Acquires Aimia Pet Healthco

February 9, 2024

Veterinary

Better Choice Company (NYSE: BTTR) has acquired all issued and outstanding common shares of Aimia Pet Healthco Inc. The acquisition gives Better Choice in-house control of Aimia's GLP-1 related R&D and enables the company to manage clinical trials and develop weight-loss supplements/treatments for pets under its Halo brand.

Better Choice Company Acquires Halo (Purely for Pets) and Closes $28M Financing

December 20, 2019

Consumer Products

Better Choice Company, Inc. (BTTR) has completed its acquisition of Halo, Purely for Pets, adding the 30-year premium holistic pet food brand to its animal health and wellness portfolio. The Company also closed $28 million of senior secured financing as part of the transaction; total consideration for Halo was approximately $46.9 million (cash, junior notes and equity), and Halo’s CEO Werner von Pein and CSO Rob Sauermann will remain to run the business.

Mountain Crest Acquisition Corp II Completes Business Combination with Better Therapeutics

October 29, 2021

Healthcare Services

Mountain Crest Acquisition Corp II completed a business combination with Better Therapeutics, taking the prescription digital therapeutics company public on Nasdaq under the ticker BTTX. The transaction generated approximately $70 million in gross proceeds (including a PIPE led by Farallon Capital Management, RS Investments, Sectoral Asset Management and Monashee Investment Management) and included a contingent credit facility from Hercules Capital to fund clinical development and regulatory efforts for Better Therapeutics' lead product, BT-001.

McKesson Acquires Rx Savings Solutions

September 19, 2022

Healthcare Services

McKesson Corporation has signed a definitive agreement to acquire Rx Savings Solutions (RxSS) for up to $875 million (approximately $600M upfront plus up to $275M contingent consideration). The acquisition brings RxSS's prescription price-transparency and medication adherence capabilities into McKesson's Prescription Technology Solutions business to expand medication access, affordability and outcomes-management offerings for payers, employers and patients.

Click Therapeutics Acquires Assets of Better Therapeutics, Inc.

May 22, 2024

Medical Devices

Click Therapeutics has acquired the assets of Better Therapeutics, Inc., including the FDA-authorized digital therapeutic AspyreRx (BT-001) and development candidates BT-002, BT-003 and BT-004. Click will integrate Better’s intellectual property into its AI-enabled platform to accelerate development of obesity and cardiometabolic digital therapeutics, optimizing programs for use alongside anti-obesity and diabetes medications.

Option Care Health Acquires Houston-based BioCureRx for $18.5M

May 6, 2021

Healthcare Services

Option Care Health paid $18.5 million to acquire Houston-based BioCureRx, a regional provider of chronic care therapies. The purchase expands Option Care's regional footprint in home and alternate-site infusion services as the company increases M&A activity.